These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19838659)
21. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies. Rodrigues PG; Bringhenti RN; do Nascimento JF; Joelsons G; dos Santos M; Pereira S; Veronese FV Int J Clin Exp Pathol; 2014; 7(5):2185-98. PubMed ID: 24966927 [TBL] [Abstract][Full Text] [Related]
22. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726 [TBL] [Abstract][Full Text] [Related]
23. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule]. Sun W; Li CQ; Chen JH; Shao JD; Zhou D; Zhang L; Gao K Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882 [TBL] [Abstract][Full Text] [Related]
24. Genetic mapping of blood pressure quantitative trait loci in Milan hypertensive rats. Zagato L; Modica R; Florio M; Torielli L; Bihoreau MT; Bianchi G; Tripodi G Hypertension; 2000 Nov; 36(5):734-9. PubMed ID: 11082136 [TBL] [Abstract][Full Text] [Related]
25. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647 [TBL] [Abstract][Full Text] [Related]
26. Expression of podocyte-associated molecules in acquired human kidney diseases. Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460 [TBL] [Abstract][Full Text] [Related]
27. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss. Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455 [TBL] [Abstract][Full Text] [Related]
28. Adducin polymorphism: detection and impact on hypertension and related disorders. Bianchi G; Ferrari P; Staessen JA Hypertension; 2005 Mar; 45(3):331-40. PubMed ID: 15699449 [TBL] [Abstract][Full Text] [Related]
29. The contribution of podocytes to chronic allograft nephropathy. Pippin J; Kumar V; Stein A; Jablonski P; Shankland SJ; Davis CL Nephron Exp Nephrol; 2009; 111(1):e1-10. PubMed ID: 19052472 [TBL] [Abstract][Full Text] [Related]
30. alpha-adducin may control blood pressure both in rats and humans. Bianchi G; Tripodi MG; Casari G; Torielli L; Cusi D; Barlassina C; Stella P; Zagato L; Barber BR Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S7-9. PubMed ID: 9072448 [TBL] [Abstract][Full Text] [Related]
31. Adducin polymorphisms and the treatment of hypertension. Manunta P; Citterio L; Lanzani C; Ferrandi M Pharmacogenomics; 2007 May; 8(5):465-72. PubMed ID: 17465710 [TBL] [Abstract][Full Text] [Related]
32. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Wang JG; Staessen JA; Barlassina C; Fagard R; Kuznetsova T; Struijker-Boudier HA; Zagato L; Citterio L; Messaggio E; Bianchi G Kidney Int; 2002 Dec; 62(6):2152-9. PubMed ID: 12427140 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm. Manunta P; Bianchi G J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S30-5. PubMed ID: 16565244 [TBL] [Abstract][Full Text] [Related]
34. 35H, a sequence isolated as a protein kinase C binding protein, is a novel member of the adducin family. Dong L; Chapline C; Mousseau B; Fowler L; Ramsay K; Stevens JL; Jaken S J Biol Chem; 1995 Oct; 270(43):25534-40. PubMed ID: 7592723 [TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of the gamma-adducin gene (Add3) in mice reveals differences in alpha-adducin interactions in erythroid and nonerythroid cells. Sahr KE; Lambert AJ; Ciciotte SL; Mohandas N; Peters LL Am J Hematol; 2009 Jun; 84(6):354-61. PubMed ID: 19425068 [TBL] [Abstract][Full Text] [Related]
36. alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Torielli L; Tivodar S; Montella RC; Iacone R; Padoani G; Tarsini P; Russo O; Sarnataro D; Strazzullo P; Ferrari P; Bianchi G; Zurzolo C Am J Physiol Renal Physiol; 2008 Aug; 295(2):F478-87. PubMed ID: 18524856 [TBL] [Abstract][Full Text] [Related]
37. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway. Liu B; He Y; Lu R; Zhou J; Bai L; Zhang P; Ye S; Wu J; Liang C; Zhou Y; Zhou J Biomed Pharmacother; 2018 May; 101():635-647. PubMed ID: 29518610 [TBL] [Abstract][Full Text] [Related]
38. IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy. Peng W; Pei GQ; Tang Y; Tan L; Qin W J Transl Med; 2019 Dec; 17(1):406. PubMed ID: 31796125 [TBL] [Abstract][Full Text] [Related]
39. Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Gilligan DM; Lozovatsky L; Gwynn B; Brugnara C; Mohandas N; Peters LL Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10717-22. PubMed ID: 10485892 [TBL] [Abstract][Full Text] [Related]
40. beta-adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the alpha- and gamma-adducin subunits. Porro F; Rosato-Siri M; Leone E; Costessi L; Iaconcig A; Tongiorgi E; Muro AF Genes Brain Behav; 2010 Feb; 9(1):84-96. PubMed ID: 19900187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]